UroGen Pharma to participate in September investor conferences
UroGen Pharma Ltd. said it will participate in investor conferences in September 2026.
PRINCETON, N.J., Sept.
02, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd.
NASDAQ:URGN, a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in Septe…